Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-15-215533
Filing Date
2015-06-08
Accepted
2015-06-08 08:04:59
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM F-1 d881786df1a.htm F-1/A 3185179
2 EX-1.1 d881786dex11.htm EX-1.1 282213
3 EX-5.1 d881786dex51.htm EX-5.1 22822
4 GRAPHIC g881786g07u80.jpg GRAPHIC 63188
5 GRAPHIC g881786g19o44.jpg GRAPHIC 103409
6 GRAPHIC g881786g37d99.jpg GRAPHIC 34598
7 GRAPHIC g881786g79y92.jpg GRAPHIC 56257
8 GRAPHIC g881786g81w19.jpg GRAPHIC 66215
9 GRAPHIC g881786g88q92.jpg GRAPHIC 97999
10 GRAPHIC g881786g98r35.jpg GRAPHIC 81505
  Complete submission text file 0001193125-15-215533.txt   4185458
Mailing Address JOUKAHAISENKATU 6 TURKU H9 FI-20520
Business Address JOUKAHAISENKATU 6 TURKU H9 FI-20520 358-2-274-8900
Biotie Therapies Corp. (Filer) CIK: 0001579695 (see all company filings)

EIN.: 000000000 | State of Incorp.: H9 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-204147 | Film No.: 15917388
SIC: 2834 Pharmaceutical Preparations